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Δ5 and Δ6 fatty acid desaturases are critical enzymes in the pathways for the 
biosynthesis of the polyunsaturated fatty acids (PUFA) arachidonic, eicosapentanoic 
and docosahexanoic acids.  They are encoded by distinct genes in mammals and in 
Caenorhabditis elegans. This paper describes a cDNA isolated from zebrafish (Danio 
rerio) with high similarity to mammalian Δ6 desaturase genes. The 1590 bp sequence 
specifies a protein that, in common with other fatty acid desaturases, contains an N-
terminal cytochrome b5 domain and three histidine boxes, believed to be involved in 
catalysis.  When the zebrafish cDNA was expressed in Saccharomyces cerevisae it 
conferred the ability to convert linoleic acid (18:2n-6) and α-linolenic acid (18:3n-3) 
to their corresponding Δ6 desaturated products, 18:3n-6 and 18:4n-3. However, in 
addition, it conferred on the yeast the ability to convert di-homo-γ-linoleic acid 
(20:3n-6) and eicosatetraenoic acid (20:4n-3) to arachidonic acid (20:4n-6) and 
eicosapentanoic acid (20:5n-3), respectively, indicating that the zebrafish gene 
encodes an enzyme having both Δ5 and Δ6 desaturase activity. This is the first report 
of a functionally characterized desaturase enzyme of fish, and the first report of a fatty 
acid desaturase in any species with both Δ5 and Δ6 activity.   The zebrafish Δ5/Δ6 

















Vertebrates lack the Δ12 and Δ15 fatty acid desaturases responsible for converting 
oleic acid (18:1n-9) into linoleic acid (18:2n-6) and α-linolenic acid (18:3n-3), and 
are thus unable to biosynthesize polyunsaturated fatty acids (PUFA) de novo (1,2).  
PUFA are, therefore, essential dietary nutrients for vertebrates (1,2). The 
physiologically active PUFA are arachidonic acid (AA, 20:4n-6), eicosapentanoic 
acid (EPA, 20:5n-3) and docosahexanoic acid (DHA, 22:6n-3), which are required for 
optimal health and normal development of vertebrates (3-6). The pathway from 
18:2n-6 to AA, and from 18:3n-3 to EPA involves desaturations at the Δ6 and Δ5 
positions in the carbon backbone, and an intermediate 2-carbon chain elongation step 
(7).  Production of DHA from EPA requires an additional desaturation and 2-carbon 
chain elongation, although the mechanism may be more complicated (8).   However, 
there is considerable variation between animal species in their abilities to synthesize 
the C20 and C22 PUFA from the plant-derived C18 precursors 18:2n-6 and 18:3n-3.  
Some animals, notably extreme carnivores, have a very limited ability to synthesize 
C20 and C22 PUFA, and consequently have a strict requirement for a dietary source of 
pre-formed C20 and C22 PUFA (9-12). While humans generally possess the ability to 
synthesize C20 and C22 PUFA from linoleic and α-linolenic acids, dietary changes as a 
consequence of intensification of agriculture have resulted in an increase in the 18:2n-
6/18:3n-3 ratio in foods (13).  There is considerable evidence that this has had, and 
continues to have, negative impacts on health and development in affected 
populations (4,13).  The dietary 18:2n-6/18:3n-3 ratio appears to have increased due 
to a steady decline in dietary n-3 fatty acids over a period of several hundred years, 
and this has been compounded by an increased dietary intake of 18:2n-6 in recent 
decades, particularly in western societies (13-16).  
         Meeting the dietary demands of a burgeoning human population for a correct 
dietary balance of PUFA, and at levels required for normal health and development, is 
a major challenge. Clearly, an understanding of the molecular basis of PUFA 
biosynthesis could underpin efforts to meet this challenge. However, until recently, 
and although the biochemical pathways involved in PUFA synthesis were described, 
little was known of the enzymes involved and of the factors affecting their 
function(s).  Some progress has been made recently in characterizing the elongase and 
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desaturases involved in PUFA synthesis (17).  Full length cDNAs for Δ6 desaturases 
have been isolated from the nematode Caenorhabditis elegans  (18), rat (19), mouse 
and human (20).   Fatty acid Δ5 desaturase genes have been isolated from C. elegans 
(21,22) and human (23,24). 
We have undertaken to study the PUFA synthesis pathway in fish, for two 
reasons. First, fish are an important source of PUFA, especially of the long chain C20 
and C22 n-3 PUFA that are often deficient in human diets (14-16).  Second, there is 
wide variation between fish species in their ability to synthesize PUFA (25-27).  
Many freshwater species such as trout, tilapia and carp are able to convert dietary C18 
precursor fatty acids to AA, EPA and DHA. However, marine species such as turbot 
and sea bream, which are inherently piscivorous, have very limited abilities to 
perform these conversions (26-31).  Comparison of the genes encoding key elements 
in the fatty acid desaturation pathway between freshwater and marine species may, 
therefore, increase knowledge of the molecular components of the pathway itself, and 
of the molecular genetic basis of phenotypic variation in PUFA biosynthesis.   
           We have recently demonstrated that zebrafish (D. rerio) share the capacity of 
other freshwater fish species to synthesize C20 and C22 PUFA from vegetable oil-
derived C18 dietary precursors (32).  Therefore, because Δ6 desaturation is generally 
considered to be the rate-limiting step in PUFA synthesis (33), we have initially 
targeted the Δ6 desaturase gene(s) of zebrafish. Here we describe the cloning and 
functional characterization of a novel fatty acid desaturase gene obtained from 
zebrafish, which, uniquely among such genes described to-date, has both Δ5 and Δ6 
desaturation activities. 
 
Materials and Methods 
Isolation of a zebrafish desaturase cDNA and sequence analysis. A zebrafish EST 
sequence (Genbank accession no. AI497337) was identified that displayed high 
homology to mammalian Δ5 and Δ6 desaturase genes.  cDNA was synthesized from 
zebrafish liver total RNA using MMLV reverse transcriptase primed by the 
oligonucleotide, 5’-GATAGCGGCCGCGTTTTTTTTTTTTTTTT(AGC)-3’. A 
portion of this cDNA was then subjected to PCR amplification (Ready-to-Go PCR 
beads; Amersham Pharmacia Biotech) with the primer described above and an 
oligonucleotide (5’-ATGGGTGGCGGAGGACAGC-3’) predicted from the zebrafish 
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EST sequence to contain the protein initiation codon.  Amplification involved an 
initial denaturation step at  94 oC for 1 min, followed by 30 cycles of denaturation at 
94 oC for 30 s, annealing at 57 oC for 30 s, and extension at 72 oC for 3 minutes. The 
products were cloned into the pYES2 plasmid (Invitrogen Ltd., Paisley, U.K.) using 
standard methods, and nucleotide sequences were determined using a Perkin Elmer 
ABI-377 DNA sequencer. Deduced amino acid sequences were aligned using 
ClustalX and sequence phylogenies were predicted using the Neighbour Joining 
method of Saitou and Nei (34). Confidence in the resulting phylogenetic tree branch 
topology was measured by bootstrapping the data through 1000 iterations. 
Expression of the zebrafish desaturase cDNA. The coding sequence of the 
zebrafish cDNA was amplified using the forward primer 5’-
CCCAAGCTTACTATGGGTGGCGGACAGC-3’ and the reverse primer 5’-
CCGCTGGAGTTATTTGTTGAGATACGC-3’), containing HindIII and XhoI sites, 
respectively.  The amplified product was ligated into the HindIII and XhoI sites of the 
pYES yeast expression vector (Invitrogen). The resulting plasmid constuct, 
pYESZFB10, was transformed into Saccharomyces cerevisiae (strain INVSc1) using 
the EasyComp transformation kit (Invitrogen). Yeast transformed with either the 
pYES vector or with pYESZFB10 were cultured overnight in 2% raffinose, 0.67% 
nitrogen base, 1% tergitol type NP-40 and 0.19% uracil dropout media at 300C.  The 
cultures were then diluted to an OD600 of 0.4 and grown until they reached an OD600 
of 1, after which expression of the transgene was induced by the addition of galactose 
to 2% w/v . At this point the cultures were supplemented with one of 0.5mM 18:2(n-
6), 18:3(n-3), 20:3(n-6) or 20:4(n-3), and then maintained at 300C in a shaking 
incubator.  Samples were taken for analysis 48 hours following galactose induction. 
Fatty acid analysis.   Approximately equal amounts of yeast cells were transferred 
into glass conical test tubes after determination of culture densities at OD600.  The 
cells were collected by centrifugation at 500 x g for 2 min, the pellets washed twice 
with 5 ml of ice-cold Hanks balance salt solution and dried under a stream of oxygen - 
free nitrogen (OFN).   Fatty acid methyl esters (FAME) were prepared by incubating 
the dried yeast cells directly with 1 ml of methylation reagent containing 10 % (v/v) 
concentrated HCl, 5 % (v/v) 2,2-dimethoxypropane and 85% (v/v) dry methanol  for 1 
hour at 850C.  After incubation, FAME were extracted by the addition of 1 ml of 1% 
NaCl solution and 0.5 ml of hexane containing 0.01% butylated hydroxytoluene as 
antioxidant. The mixture was vigorously mixed and centrifuged at 600 x g for 5 min 
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to promote phase separation.  The top phase was carefully removed and filtered 
through Whatman No. 1 filter paper into a clean glass test tube, and the solvent 
evaporated under a stream of OFN.  The FAME were purified by thin-layer 
chromatography and then resuspended in hexane, all as described previously (35).  
FAME were separated in a Fisons GC8160 gas chromatograph equipped with a 
chemically bonded CP Wax 52CB fused silica wall coated capillary column (30 m x 
0.32 mm i. d., Chrompack U.K. Ltd., London) with an on-column injection system 
and flame ionization detection. Hydrogen was used as carrier gas with an oven 
thermal gradient from an initial 50 ºC to 180 oC at 40 ºC/min, and then to a final 
temperature of 235 oC at 2 ºC/min.  Individual FAME were identified by comparison 
with known standards, with a well-characterized fish oil, and by reference to 
published data, as described previously (35).  FAME were quantified using a directly 
linked PC operating Chrom-Card Software (Thermo-Quest Italia S.P.A., Milan, Italy). 
All solvents contained 0.01% butylated hydroxytoluene as an antioxidant. 
Gas chromatography-Mass Spectrometry (GC-MS).  The identities of fatty acids 
and positions of their double bonds were confirmed by subjecting the picolinyl esters 
to electron ionization (EI) GC-MS.  Free fatty acids were prepared from FAME by 
alkaline hydrolysis as described by Christie (36).  Picolinyl esters were prepared by 
the method of Balazy and Nies (37).  This involves activating the free fatty acid by 
reaction with 1,1’-carbonyldiimidazole to form the imidazolide, which then reacts 
with 3-(hydroxymethyl)pyridine under basic conditions to form the picolinyl ester. 
GC-MS of the picolinyl esters was performed using a Fisons GC8000 gas 
chromatograph coupled to an MD800 mass spectrometer (Fisons Instruments, 
Crawley, U.K.). The gas chromatograph was equipped with a fused silica capillary 
column (60 m x 0.32 mm i.d, 0.25 mm internal film thickness) coated with Zebron 
ZB-Wax (Phenomenex, Macclesfield, U.K.) and used helium as carrier gas.  Samples 
were applied using on-column injection with the oven temperature programmed to 
rise from 80 oC to 250 oC at 40 oC per minute.   
     
Materials.  Eicosatetraenoic acid (20:4n-3; > 98% pure) was purchased from Cayman 
Chemical Co., Ann Arbor, U.S.A.  Linoleic (18:2n-6), α-linolenic (18:3n-3) and 
eicosatrienoic (20:3n-6) acids (all >99% pure), BHT, 1,1’-carbonyldiimidazole, 2,2-
dimethoxypropane, fatty acid-free BSA, galactose, 3-(hydroxymethyl)pyridine and 
HBSS, nitrogen base, raffinose, tergitol NP-40 and uracil dropout medium were 
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obtained from Sigma Chemical Co. Ltd., Dorset, UK.   TLC (20- x 20-cm x 0.25-mm) 
plates precoated with silica gel 60 (without fluorescent indicator) were purchased 
from Merck, Darmstadt, Germany.  All solvents were HPLC grade and were from 
Rathburn Chemicals, Peebleshire, U.K.  
 
Results 
Sequencing revealed that the zebrafish cDNA (Genbank accession number 
AF309556) comprised 1590 bp, which included an open reading frame specifying a 
protein of 444 amino acids. The protein sequence included a number of characteristic 
features of microsomal fatty acid desaturases, including three histidine boxes (Fig. 1). 
The protein sequence also contained an N-terminal cytochrome b5 domain containing 
the heme-binding motif, H-P-G-G, similar to that of other fatty acid desaturases. 
Further, the third histidine box contained a glutamine residue substituted for the first 
histidine.  The amino acid sequence predicted by the zebrafish ORF indicated that the 
desaturase candidate possessed 64% identity and 78% similarity to human Δ6 
desaturase (Genbank accession number AF126799) and possessed 58% identity and 
75% similarity to human Δ5 desaturase (Genbank accession number AF199596). 
Phylogenetic analysis, comparing a variety of Δ5 and Δ6 desaturases, clustered the 
zebrafish sequence with mammalian Δ6 desaturase sequences, and with an 
uncharacterized, putative fish Δ6 desaturase sequence (Fig.2).  
         The zebrafish desaturase cDNA was functionally characterized by determining 
the fatty acid profiles of transformed S. cerevisiae containing either the pYES vector 
alone or the vector with the zebrafish cDNA insert (pYESZFB10), grown in the 
presence of either 18:2n-6, 18:3n-3, 20:3n-6 or 20:4n-3.  The fatty acid composition 
of the yeast transformed with the vector alone showed the four main fatty acids 
normally found in S. cerevisiae, namely 16:0, 16:1n-7, 18:0 and 18:1n-9, together 
with the four exogenously derived fatty acids (not shown).  This is consistent with the 
fact that S. cerevisiae does not possess Δ5 or Δ6 fatty acid desaturase activities. 
Additional peaks were observed in the profiles of pYESZFB10-transformed yeast 
grown in the presence of the Δ6 desaturase substrate fatty acids, 18:2n-6 and 18:3n-3, 
and also in the profiles of pYESZFB10-transformed yeast grown in the presence of 
the Δ5 desaturase substrate fatty acids, 20:3n-6 and 20:4n-3 (Fig.3A-D). Based on GC 
retention times, the additional peaks associated with the presence of the zebrafish 
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cDNA, indicated in Fig. 3A-D, were identified as 18:3n-6, 18:4n-3, 20:4n-6 and 
20:5n-3, respectively.  
         The FAME samples from the transformed yeast incubated with the exogenous 
PUFA were converted to picolinyl esters and subjected to EI GC-MS to positively 
identify the structures represented by the additional PUFA peaks produced in cultures 
containing pYESZFB10.   The samples all showed prominent ions at m/z = 92, 108, 
151 and 164, which are characteristic of picolinyl esters representing fragments about 
the pyridine ring (Fig.4) (38). The EI spectra of the additional fatty acid in 
pYESZFB10p-transformed yeast incubated with 18:2n-6 showed a fragmentation 
pattern with a mass ion of 369 m/z and prominent peaks at 354, 340, 326, 312, 298, 
272, 258, 232, 218 and 192 m/z (Fig. 4A). The initial interval of 15 (369-354) 
represented the terminal methyl and was followed by four intervals of 14 indicating 
four methylene groups. The intervals of 26 (298-272, 258-232 and 218-192) denoted 
the positions of three double bonds, indicating that this fatty acid is Δ12,9,618:3 = 18:3n-
6.  The EI spectra of the additional fatty acid from cells incubated with 18:3n-3 
showed a mass ion of 367 m/z and fragments at 338, 312, 298, 272, 258, 232, 218 and 
192 m/z confirming this fatty acid as Δ15,12,9,618:4 = 18:4n-3 (Fig.4B).   The EI spectra of 
the additional fatty acid produced in cells incubated with 20:3n-6 showed a 
fragmentation pattern with a mass ion of 395 m/z and prominent ions at intervals of 26 
(324-298, 284-258, 244-218 and 204-178 m/z ) denoting the position of the double 
bonds and indicating that this fatty acid is Δ14,11,8,520:4 = 20:4n-6 (Fig.4C).  Similarly, 
the EI spectra of the additional fatty acid in cells incubated with 20:4n-3 showed a 
fragmentation pattern with a mass ion of 393 m/z with prominent ions at intervals of 
26 (364-338, 324-298, 284-258, 244-218 and 204-178 m/z) confirming that this fatty 
acid is Δ17,14,11,8,520:5 = 20:5n-3 (Fig.4D).  The GC-MS data confirmed that the 
zebrafish clone is a fatty acid desaturase that introduces double bonds into 18:2n-6 
and 18:3n-3 at the Δ6 position, and also into 20:3n-6 and 20:4n-3 at the Δ5 position. 
  Thus, the analyses revealed that the cells transformed with pYESZFB10 had 
acquired functional Δ6 and Δ5 fatty acid desaturase activity.  Based on the 
percentages of substrate fatty acids converted to product, the zebrafish gene is more 
active with Δ6 desaturase substrates than with Δ5 substrates, and preferentially 




The 1590 bp open reading frame of the zebrafish cDNA encodes a protein with 
substantial similarity to vertebrate Δ6 desaturases. Overall amino acid identities are 
64% to human Δ6 desaturase and 58% to human Δ5 desaturase. In addition, the 
zebrafish protein contains a similar N-terminal cytochrome b5-like domain and the 
three catalytically important histidine boxes conserved in all members of the 
desaturase gene family.  It also includes the variant third histidine box that appears to 
be typical of Δ5 and Δ6 desaturase genes described to-date.  
The analyses demonstrated unequivocally that the novel zebrafish cDNA 
encodes a polypeptide with both Δ5 and Δ6 fatty acid desaturase activities, with slight 
biases towards n-3 substrates and Δ6 function.  
Phylogenetic analysis indicates that, with respect to functionally characterized 
genes, the zebrafish sequence has highest homology with mammalian Δ6 desaturases, 
with human Δ5 desaturase appearing to be distinct from the Δ6 desaturase sequences. 
Human Δ5 and Δ6 desaturase genes (FADS1 and FADS2 respectively) are clustered 
together with a related gene (FADS3) of unknown function on chromosome 11, and 
have presumably arisen from a gene duplication event (39). The fact that the Δ5 and 
FADS3 sequences fall on distinct branches of the phylogenetic tree from that 
occupied by the Δ6 sequences suggests that this gene duplication event(s) pre-dates 
the divergence of mammalian and fish evolutionary lines. This suggests that a 
homologue of the human Δ5 gene should exist in fish species. Interestingly, the 
nematode C. elegans also possesses a cluster of Δ5 and Δ6 desaturase genes that 
appear to have arisen by gene duplication.  However, this duplication clearly occurred 
after the divergence of nematodes and vertebrates (18,21). Both the mammalian and 
nematode Δ5 and Δ6 desaturase enzymes have distinct, non-overlapping substrate 
specificities. It is, therefore, remarkable that the zebrafish desaturase, when expressed 
in S. cerevisiae, exhibits both Δ5 and Δ6 fatty acid desaturase activities with a distinct 
preference for n-3 compared to n-6 substrates. 
      Although more fatty acid desaturase genes may be found in both zebrafish and 
mammals, it is conceivable that the bi-functional desaturase described here is a 
component of a prototypic vertebrate PUFA biosynthetic pathway that has persisted in 
a freshwater fish species.  That humans and other mammals have two distinct 
enzymes for Δ5 and Δ6 desaturation may be an adaptation to a terrestrial diet 
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providing relatively lower amounts of pre-formed C20 and C22 PUFA than the diets of 
a vertebrate ancestor that they share with freshwater fish. Functional divergence of the 
products of a putative ancient gene duplication event is a possible mechanism 
underlying adaptation to such a dietary change.    
Conversely, the apparent deficiencies in the fatty acid desaturation pathway in 
some marine fish species, many of which are strictly piscivorous, may be a result of 
relaxation of constraints on a prototypic pathway in an environment providing a diet 
that is naturally rich in C20 and C22 PUFA.  Certainly, the discovery of a bifunctional 
enzyme in zebrafish is consistent with findings in the piscivorous marine species, 
turbot (Scophthalmus maximus).  In turbot, a deficiency in the fatty acid 
desaturation/elongation pathway has been ascribed to lack of C18-20 elongase function, 
while both Δ6 and Δ5 desaturase capabilities have been retained (40). However, in 
another marine species, gilthead sea bream (Sparus aurata), a block in the fatty acid 
desaturation/elongation pathway has been identified as a deficiency in Δ5 desaturase 
activity (41).  In this case it is possible that an homologous desaturase enzyme has 
lost significant Δ5 desaturase activity, thus limiting the efficiency of the PUFA 
biosynthetic pathway in gilthead sea bream. Studies of the desaturase genes of a range 
of fish species are ongoing with the purpose of examining these possibilities.  
The ability of fish to provide 20:5n-3 and 22:6n-3 for human and other animal 
diets has become an increasingly important subject in recent years following the 
global stagnation and decline of capture marine fisheries (42).  These have hitherto 
been the major source of 20:5n-3 and 22:6n-3 in human and animal diets (13).  
Increased fish farming can potentially offset the effects of this decline in a key marine 
resource.  However, where farmed marine species are concerned, a dietary source of 
20:5n-3 and 22:6n-3 is required, and this has hitherto been provided by fish oils from 
captured marine “feed species” such as sand eels, capelin and anchovies (42). Such 
“feed species” are themselves finite resources which, in the case of anchovies, is 
markedly reduced by climatic phenomena such as El Nino. Understanding the 
molecular basis of the differences between marine and freshwater fish in their abilities 
to synthesize 20:5n-3 and 22:6n-3 may suggest ways in which the reliance of farmed 
marine species on marine fish oils could be reduced.  
Here we report for the first time a fatty acid desaturase with both Δ6 and Δ5 
activities.  Such an enzyme could contribute to a biotechnological solution for 20:5n-3 
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and 22:6n-3 production, ultimately relieving pressure for unsustainable extraction of 
these key nutrients from natural marine sources. 
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Legends to Figures: 
 
Figure 1. Alignment of the predicted amino acid sequences of the zebrafish 
desaturase (DRD5/6) and human Δ5 (HSFADS1) and Δ6 desaturases (HSFADS2). 
The three ORFs encode 444 amino acid residues. Identical amino acids are in black, 
the cytochrome b5-like domain is underlined by asterisks and the three histidine-rich 
domains are underlined. 
 
Figure 2. Phylogeny of desaturase deduced amino acid sequences. Sequences marked 
with an asterisk are not functionally characterized. Data base accession numbers for 
the nucleic acid sequences are indicated. Conditions used for neighbor joining tree 
construction  are described in the text and were applied using ClustalW and NJplot.  
Horizontal branch lengths are proportional to the number of amino acid replacements 
per position, the scale bar indicating this value. Numbers represent the percentage 
frequencies with which the tree topology presented here was replicated after 1000 
bootstrap iterations. 
 
Figure3. Identification of fatty acid desaturation products in transgenic yeast. FAMEs 
were extracted from yeast transformed with pYESZFB10 grown in the presence of 
either A: 18:2n-6, B: 18:3n-3, C: 20:3n-6, and D: 20:4n-3. The first four peaks in 
panels A-D are 16:0, 16:1n-7, 18:0 and 18:1n-9, respectively. The fifth peaks in each 
panel are the exogenously added fatty acids 18:2n-6 (A), 18:3n-3 (B), 20:3n-6 (C), 
and 20:4n-3 (D), respectively. The sixth peaks in each panel, arrowed, were 
tentatively identified (based on retention times) as 18:3n-6 (A), 18:4n-3 (B), 20:4n-6 
(C) and 20:5n-3 (D), respectively. 
 
Figure 4. Mass spectra of the arrowed novel peaks in Figure 3.   Picolinyl esters were 
prepared from FAME extracted from yeast transformed with pYESZFB10 grown in 
the presence of either A: 18:2n-6, B: 18:3n-3, C: 20:3n-6, and D: 20:4n-3, and 
analyzed by GC-MS as described in the Methods section.  The identities of the novel 
peaks were confirmed as A: 18:3n-6, B: 18:5n-3, C: 20:4n-6, D: 20:5n-3. 
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Table 1.  pYESZFB10 Substrate conversion (%) and activity type 
 
Substrate fatty acid Substrate conversion Desaturase activity 
18:2n-6 11.7 Δ6 
18:3n-3 29.4 Δ6 
20:3n-6 8.3 Δ5 
20:4n-3 20.4 Δ5 
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